| Atherosclerosis: current pathogenesis and therapeutic options C Weber, H Noels Nature medicine 17 (11), 1410-1422, 2011 | 2724 | 2011 |
| Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection A Zernecke, K Bidzhekov, H Noels, E Shagdarsuren, L Gan, B Denecke, ... Science signaling 2 (100), ra81-ra81, 2009 | 1639 | 2009 |
| MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 A Schober, M Nazari-Jahantigh, Y Wei, K Bidzhekov, F Gremse, ... Nature medicine 20 (4), 368-376, 2014 | 695 | 2014 |
| MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages M Nazari-Jahantigh, Y Wei, H Noels, S Akhtar, Z Zhou, RR Koenen, ... The Journal of clinical investigation 122 (11), 4190-4202, 2012 | 599 | 2012 |
| The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease Y Döring, L Pawig, C Weber, H Noels Frontiers in physiology 5, 212, 2014 | 343 | 2014 |
| Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting J Soppert, M Lehrke, N Marx, J Jankowski, H Noels Advanced drug delivery reviews 159, 4-33, 2020 | 294 | 2020 |
| Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives L Pawig, C Klasen, C Weber, J Bernhagen, H Noels Frontiers in immunology 6, 429, 2015 | 238 | 2015 |
| The dark side of EGFP: defective polyubiquitination M Baens, H Noels, V Broeckx, S Hagens, S Fevery, AD Billiau, ... PloS one 1 (1), e54, 2006 | 212 | 2006 |
| Platelet microparticles reprogram macrophage gene expression and function B Laffont, A Corduan, M Rousseau, AC Duchez, CHC Lee, E Boilard, ... Thrombosis and haemostasis 115 (02), 311-323, 2016 | 198 | 2016 |
| Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-κB activation S Rosebeck, L Madden, X Jin, S Gu, IJ Apel, A Appert, RA Hamoudi, ... science 331 (6016), 468-472, 2011 | 185 | 2011 |
| Vascular CXCR4 limits atherosclerosis by maintaining arterial integrity: evidence from mouse and human studies Y Döring, H Noels, EPC Van Der Vorst, C Neideck, V Egea, M Drechsler, ... Circulation 136 (4), 388-403, 2017 | 178 | 2017 |
| Arrest functions of the MIF ligand/receptor axes in atherogenesis S Tillmann, J Bernhagen, H Noels Frontiers in immunology 4, 115, 2013 | 150 | 2013 |
| The pathogenesis of MALT lymphomas: where do we stand? X Sagaert, D Wolf-Peeters, H Noels, M Baens Leukemia 21 (3), 389-396, 2007 | 146 | 2007 |
| Chemokines as therapeutic targets in cardiovascular disease: the road behind, the road ahead H Noels, C Weber, RR Koenen Arteriosclerosis, Thrombosis, and Vascular Biology 39 (4), 583-592, 2019 | 137 | 2019 |
| Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations H Noels, M Lehrke, R Vanholder, J Jankowski Nature Reviews Nephrology 17 (8), 528-542, 2021 | 128 | 2021 |
| A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2· MALT1 fusions H Noels, G van Loo, S Hagens, V Broeckx, R Beyaert, P Marynen, ... Journal of Biological Chemistry 282 (14), 10180-10189, 2007 | 111 | 2007 |
| Atheroprotective mechanisms of shear stress-regulated microRNAs RA Boon, E Hergenreider, S Dimmeler Thrombosis and haemostasis 108 (10), 616-620, 2012 | 106 | 2012 |
| Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis H Noels, J Bernhagen, C Weber Trends in cardiovascular medicine 19 (3), 76-86, 2009 | 103 | 2009 |
| Selective expansion of marginal zone B cells in Eμ-API2-MALT1 mice is linked to enhanced IκB kinase γ polyubiquitination M Baens, S Fevery, X Sagaert, H Noels, S Hagens, V Broeckx, AD Billiau, ... Cancer research 66 (10), 5270-5277, 2006 | 83 | 2006 |
| Deficiency of Endothelial Cxcr4 Reduces Reendothelialization and Enhances Neointimal Hyperplasia After Vascular Injury in Atherosclerosis-Prone Mice H Noels, B Zhou, PV Tilstam, W Theelen, X Li, L Pawig, C Schmitz, ... Arteriosclerosis, thrombosis, and vascular biology 34 (6), 1209-1220, 2014 | 73 | 2014 |
